Search for: "Epstein Becker Green" Results 161 - 180 of 1,466
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Mar 2023, 1:53 pm by Lindsay Griffiths
Pal Jalsovszky is the managing partner of Jalsovszky Law Firm in Budapest, Hungary and a member firm of the International Lawyers Network. [read post]
9 Mar 2023, 8:16 am by Epstein Becker Green
On the second episode of our four-part series on direct access laboratory testing, Bob Hearn and Megan Robertson, attorneys at Epstein Becker Green, and Dr. [read post]
Please reach out to an attorney at Epstein Becker & Green, P.C., to ensure compliance with the unique requirements of your state. [read post]
24 Feb 2023, 12:17 pm by Dean R. Singewald II and Peter M. Stein
If you find your organization is on the list and should not be, or you are preparing for the first time to object to the disclosure of your EEO-1 Type 2 data, Epstein Becker Green attorneys are ready to assist you with your response or to discuss why an objection may (or may not) be warranted. [read post]
23 Feb 2023, 8:19 am by Epstein Becker Green
On this episode, Epstein Becker Green attorneys Amy Dow, Bob Hearn, James Boiani, and Megan Robertson discuss the regulatory landscape governing direct access laboratory testing. [read post]
17 Feb 2023, 8:46 am by Michael (Mike) S. Kun and Paul DeCamp
More than a decade ago, Epstein Becker Green (EBG) created its complimentary Wage & Hour Guide for Employers app, putting federal, state, and local wage-hour laws at employers’ fingertips. [read post]
9 Feb 2023, 8:40 am by Epstein Becker Green
On this episode, Epstein Becker Green attorneys Brad Thompson and Jessika Tuazon analyze the FDA’s latest CDS guidance and discuss the challenges industry faces as it attempts to make sense of, and comply with, that guidance [read post]
2 Feb 2023, 8:53 am by Epstein Becker Green
Wendy and Epstein Becker Green attorneys Lynn Shapiro Snyder, Kevin Malone, and Helaine Fingold explore the ins and outs of PACE, the changes in recent years that have made PACE available to for-profit companies, and the specifics of the provisions in the pending federal proposed rule [read post]
30 Jan 2023, 7:40 am by Amy K. Dow
The state laws at issue require that Mifepristone be taken in the presence of a physician, who must first provide state-mandated counseling to the patient before waiting 72 hours before administering the medication.[9] For additional resources on these topics, please see Epstein Becker Green’s From Roe to Dobbs additional resources [read post]
26 Jan 2023, 8:26 am by Epstein Becker Green
On this episode, Epstein Becker Green attorneys Kate Heffernan, Marylana Helou, and Megan Robertson discuss how the changing state laws and regulations post-Dobbs may impact clinical research in different ways for different stakeholders [read post]
12 Jan 2023, 8:50 am by Epstein Becker Green
Epstein Becker Green attorneys Ted Kennedy, Jr.; Alexis Boaz; and Philo Hall discuss the current landscape of health care policy from both the legislative and regulatory perspectives and analyze which key health care issues may arise [read post]
10 Jan 2023, 8:39 am by Alaap B. Shah
Epstein Becker Green will be closely following the rulemaking process in these states as implementing regulations are developed, and as other states continue to legislate in this area. [read post]
23 Dec 2022, 11:29 am by Adam S. Forman and Nathaniel M. Glasser
Epstein, Becker & Green, P.C. will continue to monitor and publish updates on this topic. [read post]